Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29713803 | 0.97 | OPRM1 (0.59) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL31410861 | 0.90 | OPRM1 (0.60) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL29702054 | 0.89 | OPRM1 (0.66) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL30833622 | 0.89 | OPRM1 (0.66) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL31412199 | 0.89 | OPRM1 (0.66) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL30574233 | 0.89 | OPRM1 (0.64) | OPRM1OPRD1OPRK1 | |
| SCHEMBL29454482 | 0.88 | OPRM1 (0.59) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL31289573 | 0.88 | OPRM1 (0.59) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL30631567 | 0.88 | OPRM1 (0.59) | SLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL29710134 | 0.87 | SLC6A2 (0.59) | SLC6A2OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024040167-A2 | SELECTIVE MC4R LIGAND FOR TREATING OBESITY AND COGNITIVE LOSS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-02-22 | — | — | WO | claimed |
| WO-2024040167-A2 | SELECTIVE MC4R LIGAND FOR TREATING OBESITY AND COGNITIVE LOSS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-02-22 | — | — | WO | disclosed |